Tomorrow's strategy: Tomorrow will continue to focus on the digital economy, special drugs, new crown testing and other directions During the first and Second months, it is recommended to focus on medical medicine (special drugs, new crown testing) and digital economy

Tomorrow's strategy: Tomorrow will continue to focus on the digital economy, special drugs, new crown testing and other directions

During January and February, it is recommended to focus on the four main directions of medical medicine (special drugs, new crown testing), digital economy (digital currency, meta-universe, data center, etc.), infrastructure (construction), and babies and children.

Second, the digital economy: this main line has a rotating market in each sector during February (such as digital currency, cloud computing, big data, blockchain, meta-universe, Internet of Things, data centers, artificial intelligence and other rotating markets). For example: yesterday's digital currency plate collective market, today's big data plate collective market, tomorrow or next week focus on the direction of the meta-universe relay represents the digital economy market. During the month, the focus was on the 20-day line to support the trend of individual stocks related to the digital economy.

1. Digital currency: Hengbao shares 5 board successfully surpassed and replaced Cuiwei shares to become a new leader in digital currency. In addition, Hailian Jinhui, Shensi Electronics, Tianyuan Dike, New Cape, etc. pay attention to the 20-day line support to take a wave of trend market.

2. Other stocks worth paying attention to in the main line of digital economy are: meta-universes such as Zhongqingbao, Chinese Online. Big data such as Ronglian Technology, Huayang Lianzhong, Jinglan Technology, Inspur Software, Annie Shares, Zhongke Jincai, etc. pay attention to the 20-day line support and nearby participation opportunities.

Fourth, special drugs, new crown testing: this line has the opportunity to challenge the previous high market during February. At present, many shares continue to increase the volume of changes at the bottom. Special drugs such as Shu Taishen, Hanyu Pharmaceutical, Jingjing Pharmaceutical, Jianfeng Group, Yiling Pharmaceutical, etc. are expected to stand on the 20-day line in the short term and drive a wave of collective market. The new crown test focuses on Jiuan Medical, Yahuilong, Botuo Biological, Qianhong Pharmaceutical, etc

Fifth, infrastructure: this line continues to be strong and active, and it is expected to have a strong repeated market during February, and even a second and third wave of markets. Huitong Group, Chongqing Construction Engineering, Zhejiang Construction Investment, etc. are all 4 boards, and the three will compete to become the leader. In addition, Hualan Group, Jianyan Design, Zhubo Design, Tusspark Design, Zhongyan Dadi, etc. still have room to rise, and can pay attention to the low-suction layout opportunities near the 5-day line. #Today's watch##Will not look at the candlestick chart can speculate in stocks ##大盘冲击3000点, and even continue to rise, the previous account is unwinded, will you continue to stay in the stock market ##How about this year's stock market returns##Stock ##今日复盘 #